Related references
Note: Only part of the references are listed.SF3B1 mutated MDS: Blast count, genetic co-abnormalities and their impact on classification and prognosis
Sandra Huber et al.
LEUKEMIA (2022)
JAK2-V617F and interferon-α induce megakaryocyte-biased stem cells characterized by decreased long-term functionality
Tata Nageswara Rao et al.
BLOOD (2021)
Hematopoietic Stem Cell Heterogeneity Is Linked to the Initiation and Therapeutic Response of Myeloproliferative Neoplasms
Jingyuan Tong et al.
CELL STEM CELL (2021)
Reconstructing the Lineage Histories and Differentiation Trajectories of Individual Cancer Cells in Myeloproliferative Neoplasms
Debra Van Egeren et al.
CELL STEM CELL (2021)
Pathologic Spectrum and Molecular Landscape of Myeloid Disorders Harboring SF3B1 Mutations
Elise R. Venable et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2021)
Only SF3B1 mutation involving K700E independently predicts overall survival in myelodysplastic syndromes
Rashmi Kanagal-Shamanna et al.
CANCER (2021)
Multilevel defects in the hematopoietic niche in essential thrombocythemia
Ting Sun et al.
HAEMATOLOGICA (2020)
Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera
Ayalew Tefferi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS
Luca Malcovati et al.
BLOOD (2020)
Single-Cell Analyses Reveal Megakaryocyte-Biased Hematopoiesis in Myelofibrosis and Identify Mutant Clone-Specific Targets
Bethan Psaila et al.
MOLECULAR CELL (2020)
Differentiation of transplanted haematopoietic stem cells tracked by single-cell transcriptomic analysis
Fang Dong et al.
NATURE CELL BIOLOGY (2020)
Phase I and Biomarker Study of the Wnt Pathway Modulator DKN-01 in Combination with Gemcitabine/Cisplatin in Advanced Biliary Tract Cancer
Lipika Goyal et al.
CLINICAL CANCER RESEARCH (2020)
WNT Signaling in Hematological Malignancies
Michela Frenquelli et al.
FRONTIERS IN ONCOLOGY (2020)
SF3B1 mutations in the Driver Clone Increase the Risk of Evolution to Myelofibrosis in Patients with Myeloproliferative Neoplasms (MPN)
Lin-Pierre Zhao et al.
BLOOD (2020)
Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options
Harmen van Andel et al.
LEUKEMIA (2019)
Gfi1b regulates the level of Wnt/β-catenin signaling in hematopoietic stem cells and megakaryocytes
Peiman Shooshtarizadeh et al.
NATURE COMMUNICATIONS (2019)
A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients
Anne-Laure Giraudet et al.
BMC CANCER (2018)
Dual Targeting of Oncogenic Activation and Inflammatory Signaling Increases Therapeutic Efficacy in Myeloproliferative Neoplasms
Maria Kleppe et al.
CANCER CELL (2018)
Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic Leukemia
Michael Y. Choi et al.
CELL STEM CELL (2018)
Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet
Tiziano Barbuil et al.
LEUKEMIA (2018)
Classification and Personalized Prognosis in Myeloproliferative Neoplasms
J. Grinfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms
William Vainchenker et al.
BLOOD (2017)
Wnt/beta-catenin pathway: modulating anticancer immune response
Sachin Gopalkrishna Pai et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2017)
The role of LNK/SH2B3 genetic alterations in myeloproliferative neoplasms and other hematological disorders
N. Maslah et al.
LEUKEMIA (2017)
Wnt signalling pathways in chronic lymphocytic leukaemia and B-cell lymphomas
Pavlina Janovska et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Diagnosis and classification of hematologic malignancies on the basis of genetics
Justin Taylor et al.
BLOOD (2017)
LNK mutations and myeloproliferative disorders
Mary Frances McMullin et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Pathogenesis of Myeloproliferative Disorders
Jyoti Nangalia et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 11 (2016)
SIRT6 Controls Hematopoietic Stem Cell Homeostasis through Epigenetic Regulation of Wnt Signaling
Hu Wang et al.
CELL STEM CELL (2016)
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both
S. Koschmieder et al.
LEUKEMIA (2016)
The Role of β-Catenin in Bcr/Abl Negative Myeloproliferative Neoplasms: An Immunohistochemical Study
Ayfer Geduk et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2015)
Unipotent Megakaryopoietic Pathway Bridging Hematopoietic Stem Cells and Mature Megakaryocytes
Hidekazu Nishikii et al.
STEM CELLS (2015)
Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms
Pontus Lundberg et al.
BLOOD (2014)
β-catenin promotes the type I IFN synthesis and the IFN-dependent signaling response but is suppressed by influenza A virus-induced RIG-I/NF-κB signaling
Andrea Hillesheim et al.
CELL COMMUNICATION AND SIGNALING (2014)
Myeloproliferative neoplasms can be initiated from a single hematopoietic stem cell expressing JAK2-V617F
Pontus Lundberg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Deregulated WNT signaling in childhood T-cell acute lymphoblastic leukemia
O. H. Ng et al.
BLOOD CANCER JOURNAL (2014)
Canonical Wnt signaling in megakaryocytes regulates proplatelet formation
Iain C. Macaulay et al.
BLOOD (2013)
Cross talk between Wnt/β-catenin and Irf8 in leukemia progression and drug resistance
Marina Scheller et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Platelet-biased stem cells reside at the apex of the haematopoietic stem-cell hierarchy
Alejandra Sanjuan-Pla et al.
NATURE (2013)
Genetic and Pharmacologic Inhibition of β-Catenin Targets Imatinib-Resistant Leukemia Stem Cells in CML
Florian H. Heidel et al.
CELL STEM CELL (2012)
Maintenance of hematopoietic stem cells through regulation of Wnt and mTOR pathways
Jian Huang et al.
NATURE MEDICINE (2012)
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
Luca Malcovati et al.
BLOOD (2011)
Canonical Wnt Signaling Regulates Hematopoiesis in a Dosage-Dependent Fashion
Tiago C. Luis et al.
CELL STEM CELL (2011)
Physiological Jak2V617F Expression Causes a Lethal Myeloproliferative Neoplasm with Differential Effects on Hematopoietic Stem and Progenitor Cells
Ann Mullally et al.
CANCER CELL (2010)
Advances in Understanding and Management of Myeloproliferative Neoplasms
Alessandro M. Vannucchi et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice
Shu Xing et al.
BLOOD (2008)
The role of β-catenin in chronic myeloproliferative disorders
Monica P. Jauregui et al.
HUMAN PATHOLOGY (2008)
JAK2(V617F) expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis
Catherine Lacout et al.
BLOOD (2006)
Share Paper
